A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate Sir, We read with great interest the recent report from the Committee of Principal Investigators on the cooperative trial in the primary prevention ofischaemic heart disease using clofibrate (British Heart Journal, 1978 , 40, 1069 -1118 .
We note with satisfaction that our dietary prevention trial in two mental hospitals near Helsinki (Miettinen et al., 1972) was considered by the Principal Investigators in their Discussion. However, the results of our study were partly misrepresented.
On page 1101 it is stated, correctly, that 'there was a significant reduction in IHD mortality' during the experimental diet periods. However, on page 1096 the authors say that 'mortality from IHD, . . . , was not reduced in ... primary prevention trials using a diet rich in polyunsaturated fats (. . .; Miettinen et al., 1972) '. This statement is in obvious contradiction to the previous one and is false.
On page 1098 it is stated that in our study (Miettinen et al., 1972) there was 'a non-significant excess in total mortality among the experimental group taking a polyunsaturated fat diet'. This is not true. On the contrary, in our trial total mortality among the experimental groups was not higher but lower than among the control groups. The relevant mortality figures per 1000 man-years were as follows (cf. (Miettinen et al., 1973) . In this reply we showed that the remarks of Halperin and his colleagues were largely unfounded. 370
On page 1099, where the authors refer to the study of Sturdevant et al. (1973) indicating an increase in the prevalence of gallstones on a diet high in polyunsaturated fat, it might have been relevant also to mention our paper (Miettinen et al., 1976) 
